MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Caspr2 antibody associated spinal myoclonus

S. Duma, V. Fung, R. Dhanapalaratnam, A. Martin, T. Ong, L. Allport (Kogarah, Australia)

Meeting: MDS Virtual Congress 2020

Abstract Number: 270

Keywords: Myoclonus: Pathophysiology, Psychogenic movement disorders(PMD): Clinical features

Category: Myoclonus

Objective: We report two patients with spinal myoclonus and Contactin-associated protein-2 (Caspr-2)-antibodies, idiopathic in one and paraneoplastic in the other.

Background: Caspr-2-antibodies have classically been associated with limbic encephalitis, cerebellar dysfunction, neuromyotonia and Morvan’s syndrome. Caspr-2 antibodies are often associated with underlying malignancy. There has only been one previous report of Caspr-2 associated spinal myoclonus [1].

Method: Patient 1 is a 68-year-old gentleman who presented with gradually worsening, predominantly flexion, truncal jerks, consistent with propriospinal myoclonus over 5 years, initially present only when supine. The myoclonus became continuous over months. Additionally, his cognition deteriorated. There was no history of malignancy.

Patient 2 is a 65-year-old gentleman who presented with marked gait deterioration secondary to an acute on chronic subdural haematoma, on a background of cerebellar ataxia and a recent diagnosis of oesophageal cancer. Shortly following presentation, he developed truncal and abdominal jerks, consistent with propriospinal myoclonus.

In both, the jerks were irregular, variable in amplitude and severity and in patient 1, initially even distractible, consistent with psychogenic jerks.

Results: Patient 1 had positive Caspr-2-antibodies in his serum and CSF. Investigations revealed no evidence of malignancy. Clonazepam resulted in moderate improvement. He is due to commence immunotherapy.

Patient 2 had positive Caspr-2-antibodies in serum and CSF. Clonazepam, levetiracetam and methylprednisolone resulted in marked improvement. He underwent chemoradiotherapy and local resection of oesophageal cancer.

Conclusion: Our patients provide further evidence of an association between Caspr2 antibodies and spinal myoclonus. Differentiation from psychogenic myoclonus may be difficult. Diagnosis should trigger a search for underlying malignancy. 

This abstract has been submitted, but not yet accepted, to be presented at the ANZAN Annual Meeting 2020.

References: 1. Hines, H., et al., Video NeuroImages: Paraneoplastic spinal myoclonus associated with Caspr2 antibodies. Neurology, 2018. 90(14): p. 660-661.

To cite this abstract in AMA style:

S. Duma, V. Fung, R. Dhanapalaratnam, A. Martin, T. Ong, L. Allport. Caspr2 antibody associated spinal myoclonus [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/caspr2-antibody-associated-spinal-myoclonus/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/caspr2-antibody-associated-spinal-myoclonus/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley